Related Experiment Video
Updated: Jul 16, 2025

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.6K
Emergent HIV drug resistance in non-inferiority trials
Diego Ripamonti1, Maurizio Zazzi2
1Infectious Diseases Unit, ASST Papa Giovanni XXIII Hospital, Bergamo 24127, Italy.
The Lancet. HIV
|September 15, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
Retrovirus Life Cycles
46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

